(Q30499087)

8 November 2017

Coagulation and fibrinolytic activity of cerebrospinal fluid (English)

1 reference

8 November 2017

0 references

Anderson M

1

1 reference

8 November 2017

Matthews KB

series ordinal

2

1 reference

8 November 2017

Stuart J

series ordinal

3

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 May 1978

1 reference

Journal of Clinical Pathology

8 November 2017

1 reference

8 November 2017

31

1 reference

8 November 2017

5

1 reference

8 November 2017

488-492

1 reference

THE USE OF FIBRINOLYTIC ACTIVATORS IN MENINGITIS AND SIMILAR CONDITIONS.

8 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

FIBRINOLYTIC THERAPY IN MENINGITIS AND VENTRICULITIS.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Effect of mental stress on the fibrinolytic reactivity to exercise

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Estimation of cerebrospinal fluid protein

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Preoperative management of patients with ruptured intracranial aneurysms

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

A technique for routine evaluation of plasminogen in humans during streptokinase therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Fibrin/fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Plasminogen in Normal and Abnormal Human Cerebrospinal Fluid

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Urinary Fibrinogen Derivative Excretion and Intraglomerular Fibrin Deposition in Glomerulonephritis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Fibrin degradation products in the serum and cerebrospinal fluid of patients with group A meningococcal meningitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Detection of fibrinogen antigens with two latex techniques applied to urine concentrates.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

The alpha2-macroglobulin level in cerebrospinal fluid; a parameter for the condition of the blood-CSF barrier.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Intracranial Aneurysms and Subarachnoid Hemorrhage. A Cooperative Study. Antifibrinolytic Therapy in Recent Onset Subarachnoid Hemorrhage

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Fibrin-fibrinogen degradation products in cerebrospinal fluid

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Cerebrospinal fluid immunoglobulins and complement in meningococcal meningitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1145309

Determination of total protein in spinal fluid with sulphosalicylic acid and trichloroacetic acid

20 June 2018

1 reference

12 December 2020

The fibrin plate method for estimating fibrinolytic activity

1 reference

12 December 2020

Fibrin/fibrinogen degradation products in pleural exudate

1 reference

12 December 2020

Monitoring antifibrinolytic therapy in subarachnoid hemorrhage

1 reference

12 December 2020

Antifibrinolytic therapy for intracranial aneurysms

1 reference

12 December 2020

Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms

1 reference

12 December 2020

Urinary fibrin-fibrinogen degradation products in nephrotic syndrome

1 reference

12 December 2020

Serum and Urinary Fibrin/Fibrinogen Degradation Products in Glomerulonephritis

1 reference

12 December 2020

Clotting factors and fibrinogen split products in the extravasular space

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.31.5.488

1 reference

8 November 2017

1 reference

8 November 2017

1 reference